{"id":56617,"date":"2023-05-30T18:37:46","date_gmt":"2023-05-30T17:37:46","guid":{"rendered":"https:\/\/touchneurology.com\/?post_type=media_gallery&p=56617"},"modified":"2023-05-30T18:37:46","modified_gmt":"2023-05-30T17:37:46","slug":"stewart-tepper-aan-2023-atogepant-for-the-preventive-treatment-of-chronic-migraine-results-from-the-progress-phase-3-trial","status":"publish","type":"media_gallery","link":"https:\/\/touchneurology.com\/headache-disorders\/conference-hub\/stewart-tepper-aan-2023-atogepant-for-the-preventive-treatment-of-chronic-migraine-results-from-the-progress-phase-3-trial\/","title":{"rendered":"Stewart Tepper, AAN 2023: Atogepant for the preventive treatment of chronic migraine: results from the PROGRESS phase 3 trial"},"content":{"rendered":"
Prof Stewart Tepper<\/strong> (Geisal School of Medicine – Dartmouth, Hanover, NH, USA) summarizes the pivotal results of the PROGRESS phase 3 trial, evaluating the efficacy, safety, and tolerability of atogepant for preventive treatment of chronic migraine (CM). This study has very important clinical indications for the use of G pants in prevention of migraine.<\/p>\n Disclosures<\/b>: Stewart Tepper has received grants for research (no personal compensation) from Allergan\/Abbvie, Amgen, Eli Lilly, Lundbeck, Neurolief, Novartis, Satsuma and Zosano. He is a consultant and\/or member of the advisory boards (honoraria) for Aeon, Allergan\/Abbvie, Alphasights, Amgen, Aruene, Atheneum, Axsome Therapeutics, Becker Pharmaceutical Consulting, BioDelivery Sciences International, Biohaven, ClearView Healthcare Partners, ClickTherapeutics, CoolTech, CRG, Decision Resources, Defined Health, DRG, Eli Lilly, ExpertConnect, FCB Health, Fenix, GLG, Guidepoint Global, Health Advances, Health Science Communications, HMP Communications, Impel, Initiatior Pharma, InteractiveForums, Keyquest, Ki Health Partners, Krog and Partners, Lundbeck, M3 Global Research, Magnolia Innovation, MJH Holdings, Miravo Healthcare, Neurofront Therapeutics, Neurolief, Novartis, P Value Communications, Pain Insights, Inc, \u00a0Palion Medical, Pulmatrix, Putnam Associates, Rehaler, SAI MedPartners, Satsuma, Slingshot Insights, Spherix Global Insights, Strategy Inc, Synapse Medical Communication, System Analytic, Taylor and Francis, Tegus, Teva, Theranica, Tremeau, Trinity Partners, Unity HA, Vial, XOC and Zosano. He receives his salary from Dartmouth-Hitchcock Medical Center and Thomas Jefferson University. He has received CME honoraria from the American Academy of Neurology, American Headache Society, Annenberg Center for Health Sciences, Catamount Medical Education, Diamond Headache Clinic, Forefront Collaborative, Haymarket Medical Education, HMP Global, Medical Education Speakers Network, Medical Learning Institute Peerview, Migraine Association of Ireland, Miller Medical Education, National Association for Continuing Education, North American Center for\u00a0CME, The Ohio State University, Physicians\u2019 Education Resource, PlatformQ Education, Primed, Vindico Medical Education and WebMD\/Medscape.<\/p>\n Support<\/b>: Interview and filming supported by Touch Medical Media. Interview conducted by Sophie Nickelson.<\/p>\n Filmed as a highlight of\u00a0the 75th<\/sup>AAN<\/em>\u00a0Annual Meeting, 2023<\/a><\/i><\/b><\/p>\n